RETATRUTIDE 40mg
Report #105306
- Batch
- 002/26
- Laboratory
- Janoshik Analytical
- Test date
- 4 February 2026
- Listed result
- 99.278%
Retatrutide 12.73 mg/ml
Weight Management
RETATRUTIDE 40mg
Product code CLV-RETA-40
£170.99
Retatrutide 40mg under the RETAKLIK label: a single pen labelled 40mg/2.4ml, recognisable by its purple packaging.
Research use only. All products listed are supplied for laboratory and analytical research use only. They are not medicines, are not intended for human or veterinary use, and must not be used for diagnosis, treatment or consumption. Purchasers must be 18 or over.
The 40mg RETAKLIK listing holds twice the labelled Retatrutide content of the 20mg pen in the same 2.4ml volume. Retatrutide (LY3437943) is a synthetic peptide investigated as an agonist at the GIP, GLP-1 and glucagon receptors.
Composition and strength
Retatrutide, labelled 40mg/2.4ml on the carton and pen.
Format
One pre-filled pen in a purple-trimmed APEX Pharma carton.
Storage
Store refrigerated at 2–8°C. Do not freeze. Keep in the original carton, away from light.
Looking for a different strength? See Retatrutide 20mg or Retatrutide 60mg.
Supplied for laboratory research use only. Not for human or veterinary use.
| Product code | CLV-RETA-40 |
|---|---|
| Strength | — |
| Brand | APEX Pharma |
| Label name | RETAKLIK |
| Active ingredient | Retatrutide |
| Labelled strength | 40mg/2.4ml |
| Pack | 1 pre-filled pen |
| Storage | 2–8°C, do not freeze, protect from light |
| Intended use | Laboratory research only |
Composition
Retatrutide 40mg (40mg/2.4ml)
Storage
Store refrigerated at 2–8°C. Do not freeze. Keep in the original carton, away from light.
Verify your productCheck the batch number printed on your label against the report above.
All reports for this product
Packed cold in insulated, discreet and unbranded outer packaging, and sent by tracked delivery.
Orders paid before 1pm (UK time), Monday to Friday, are dispatched the same working day. Orders paid later, or at weekends and on UK bank holidays, are dispatched the next working day.
- UK Standard: £4.99, free over £100.00. 2–4 working days after dispatch
- UK Tracked Next Working Day: £9.99. Next working day when paid before 1pm (UK time), Monday to Friday
Is a Certificate of Analysis available for this product?
Published certificates are listed in the Documentation tab and in the Certificates of Analysis library. If none is shown, documentation for current stock has not been published yet.
No reviews published yet.
Write a reviewRetatrutide 40mg UK — product information
This listing is Retatrutide 40mg, supplied as a single pen under the RETAKLIK label. Retatrutide (research code LY3437943) is an investigational peptide studied as an agonist at the GIP, GLP-1 and glucagon receptors; it is not a licensed medicine in the UK. This page brings together the labelled strength, packaging details, current UK price and stock, and batch documentation where published.
The Certificate of Analysis published for current stock is in the Documentation tab above and on our COAs page. See the storage guide for storage and handling on arrival. Other strengths: Retatrutide 20mg and Retatrutide 60mg. For the combined pen see RETAKLIK 2.0 (Retatrutide + Cagrilintide), or compare listings with the compare tool. Supplied for laboratory research use only; not for human or animal use.
